228 results on '"Rosenblat, Joshua D"'
Search Results
2. Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the united states food and drug administration adverse event reporting system (FAERS)
3. Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system
4. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
5. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
6. Impact of Elevated Body Mass Index (BMI) on Cognitive Functioning and Inflammation in Persons with Post-COVID-19 Condition: A Secondary Analysis
7. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
8. Adjunctive cariprazine for major depressive disorder: a systematic review and meta-analysis
9. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
10. The Impact of Cognitive Function on Health-Related Quality of Life in Persons with Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
11. Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression
12. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine
13. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis
14. The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis
15. Corrigendum to “COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis” [Brain Behav. Immun. 111 (2023) 211–229]
16. A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review
17. Association between Cognitive Functioning, Suicidal Ideation and Suicide Attempts in Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Related Disorders: A Systematic Review and Meta-Analysis
18. The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
19. Augmentation in depression: Esketamine, a new standard?
20. Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review
21. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
22. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
23. Corrigendum to “Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in major depressive disorder” [J. Affect. Disord.. 238, 2018, pages 228–232]
24. Contributors
25. The neurodevelopmental basis of bipolar disorder: Mechanisms and implications
26. Novel therapeutic drug targets for bipolar disorder
27. Immunity as a Common Risk Pathway for Psychiatric and Medical Comorbidity
28. Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
29. Psilocybin-Assisted Therapy for Depression: A Systematic Review and Meta-Analysis
30. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
31. Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
32. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
33. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
34. List of Contributors
35. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis
36. Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
37. Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
38. Management Commentary
39. Pharmacological treatment of bipolar disorder.
40. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects
41. An update on potential pharmacotherapies for cognitive impairment in bipolar disorder
42. Association of SARS-CoV-2 Infection with Neurological Symptoms and Neuroimaging Manifestations in the Pediatric Population: A Systematic Review
43. Depression, anxiety and post-traumatic stress during the 2022 Russo-Ukrainian war, a comparison between populations in Poland, Ukraine, and Taiwan
44. Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD
45. Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity
46. Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
47. Can COVID-19 have a clinically significant effect on drug metabolism?
48. Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis
49. The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
50. Biomarkers of ketamine's antidepressant effect: An umbrella review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.